Pharmaceutical Nocturia Solution
A private pharmaceutical company is in the process of developing a patented drug to treat Nocturia and is expected to be the first to market in the space. With the size of the market, revenue is expected to be $20 billion at 15 cents a dose. The drug is a low dose combination of ibuprofen…